Shawn Maddaford
Fondateur chez Talon Pharmaceutical Services, Inc.
Provenance du réseau au premier degré de Shawn Maddaford
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Talon Pharmaceutical Services, Inc.
 Talon Pharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Talon Pharmaceutical Services, Inc. provides Pharmaceutical services. The company was founded by Shawn Maddaford and David Vaughan and is headquartered in Mississauga, CA.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Shawn Maddaford via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Bayer, Inc.
 Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada | Chemicals: Agricultural | Corporate Officer/Principal | |
| University of Toronto | College/University | Doctorate Degree | |
Quest Diagnostics Infectious Disease, Inc.
 Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ANTIBE THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Antibe Holdings, Inc.
 Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | Financial Conglomerates | Corporate Officer/Principal |
Statistiques
Internationale
| Canada | 6 |
| Etats-Unis | 3 |
Sectorielle
| Commercial Services | 3 |
| Health Technology | 3 |
| Process Industries | 2 |
| Consumer Services | 2 |
| Finance | 2 |
Opérationnelle
| Corporate Officer/Principal | 6 |
| Doctorate Degree | 1 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| David Vaughan | 8 |
- Bourse
- Insiders
- Shawn Maddaford
- Connexions Sociétés
